Find a Business Near: Whippany, NJ

Pharmaceutical Manufacturers In Whippany




Pharmaceutical Manufacturers


Below is a list of businesses listed within our directory which provide Pharmaceutical Manufacturers services. If you do not see your business within the list below, you can submit it for addition to this list. Adding your business will feature your listing above Standard listings.

Standard Listings

Business Listing   Eye Tech Pharmaceuticals - Whippany, NJ - Phone: (973) 539-6009


Business Listing   M O Industries Inc - Whippany, NJ - Phone: (973) 386-9228


Business Listing   Pfizer Inc - Whippany, NJ - Phone: (973) 581-7038


Business Listing   TestPak Inc - Whippany, NJ - Phone: (973) 887-4440


Don't see your business here? Add it and appear here!






Helpful Definition for: Pharmaceutical Manufacturers

Drug development or pharmaceutical manufacturers refers to activities undertaken after a compound is identified as a potential drug in order to establish its suitability as a medication and pharmaceutical products must be approved in Whippanyby the Food and Drug Administration (FDA) as being both safe and effective.

Depending on a number of considerations, a manufacturing company in Whippanymay apply for and be granted a patent for the drug, or the process of producing the drug, granting exclusivity rights typically for about 20 years. The owner of the patent need to recover the costs of research and development through high profit margins for the branded drug as a pharmaceutical company in the market with in Whippany .








Recent News from the Green Blog

Governor Cuomo Announces Growth Of Clean Technology Companies And Creation Of 980 Jobs

$14 million Investment in Cleantech Business Incubator Initiative Supports the Development of 141 Clean Energy Companies across the State   (Long Island, NY) Governor Andrew M. Cuomo today announced that 141 clean technology companies have been supported and primed for further growth through the Governor’s Cleantech Business Incubator initiative. The initiative has attracted more than $215 million in private capital..